Initial United States clinical and pharmacologic evaluation of misonidazole (Ro-07-0582), an hypoxic cell radiosensitizer.
D000284:Administration, Oral; D004334:Drug Administration Schedule; D004341:Drug Evaluation; D006801:Humans; D008920:Misonidazole / Q000008:administration & dosage* / Q000009:adverse effects / Q000378:metabolism; D009325:Nausea / Q000139:chemically induced; D009369:Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy; D009593:Nitroimidazoles / Q000008:administration & dosage*; D010523:Peripheral Nervous System Diseases / Q000139:chemically induced; D012677:Sensation / Q000187:drug effects; D014839:Vomiting / Q000139:chemically induced
D009593:Nitroimidazoles; D008920:Misonidazole